U.S. Attorney General Pam Bondi has dropped the federal case against Utah doctor Michael Kirk Moore Jr., who was accused of issuing fake COVID-19 vaccine certificates and discarding over $28,000 worth of government-provided vaccines. Moore, a Salt Lake County plastic surgeon, faced charges after a 2023 federal indictment, but his trial was halted earlier this month.
Bondi announced the decision Saturday on X, stating Moore "did not deserve the years in prison he was facing" and had "given his patients a choice when the federal government refused to do so." The move has sparked heated debate, especially among vaccine skeptics and political allies of former President Donald Trump.
Moore allegedly operated the scheme from his clinic, giving saline shots to minors at their parents’ request so they would believe they were vaccinated, according to a 2023 statement from the U.S. Attorney’s Office in Utah.
The decision to drop the case was praised by conservative figures. Marjorie Taylor Greene, a Trump ally, called Moore a “hero” and said, “We can never again allow our government to turn tyrannical.” Health Secretary Robert F. Kennedy Jr., known for his vaccine skepticism, praised Moore’s actions on X, claiming he deserved “a medal for his courage.”
The case’s dismissal comes amid growing scrutiny of Bondi's recent removal of Justice Department officials who were investigating Trump, raising concerns over potential political retaliation within the department.
This high-profile case underscores the continued politicization of COVID-19 vaccine policies in the U.S., where public health, personal freedom, and federal authority remain deeply contested issues.


Federal Judge Blocks Trump Administration’s Pause on New Wind-Energy Permits
Trump Claims Pardon for Tina Peters Despite No Legal Authority
Thailand Vows Continued Military Action Amid Cambodia Border Clash Despite Trump Ceasefire Claim
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
EU Court Cuts Intel Antitrust Fine to €237 Million Amid Long-Running AMD Dispute
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Environmental Group Sues to Block Trump Image on U.S. National Park Passes
Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
Preservation Group Sues Trump Administration to Halt $300 Million White House Ballroom Project
Israeli Airstrike in Gaza Targets Senior Hamas Commander Amid Ceasefire Tensions
U.S. Special Forces Intercept Ship Carrying Military Components Bound for Iran
U.S. Homeland Security Ends TSA Union Contract, Prompting Legal Challenge
Russian Drone Attack Hits Turkish Cargo Ship Carrying Sunflower Oil to Egypt, Ukraine Says
Special Prosecutor Alleges Yoon Suk Yeol Sought North Korea Provocation to Justify Martial Law 



